Keywords: bonviva, injection, set, eu, approval, swiss, major

Bonviva injection set for EU approval

Article | 06 February 2006

Print This

Swiss major Roche and UK-based giant GlaxoSmithKline say that a new four-times a year intravenous injection of the osteoperosis medication ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in